Published in Aging Dis on September 09, 2010
Contra-Directional Expression of Serum Homocysteine and Uric Acid as Important Biomarkers of Multiple System Atrophy Severity: A Cross-Sectional Study. Front Cell Neurosci (2015) 0.93
The calcineurin inhibitor Sarah (Nebula) exacerbates Aβ42 phenotypes in a Drosophila model of Alzheimer's disease. Dis Model Mech (2015) 0.79
Neuroimmunomodulation and Aging. Aging Dis (2010) 0.78
LW-AFC, a new formula derived from Liuwei Dihuang decoction, ameliorates behavioral and pathological deterioration via modulating the neuroendocrine-immune system in PrP-hAβPPswe/PS1(ΔE9) transgenic mice. Alzheimers Res Ther (2016) 0.75
A synaptic model of memory: long-term potentiation in the hippocampus. Nature (1993) 29.13
Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol (2003) 18.97
Neurogenesis in the adult human hippocampus. Nat Med (1998) 17.53
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell (1991) 15.76
Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J Physiol (1973) 14.99
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type. J Neurosci (1998) 11.63
Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol (1997) 11.57
Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol (1965) 9.18
Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J Neurosci (2007) 8.27
NFAT signaling: choreographing the social lives of cells. Cell (2002) 8.17
Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature (1992) 8.15
Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med (2003) 6.79
Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A. Nature (1991) 6.30
Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci (2007) 6.27
Glutamate induces calcium waves in cultured astrocytes: long-range glial signaling. Science (1990) 6.02
Calcineurin: form and function. Physiol Rev (2000) 5.26
Involvement of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term depression. Nature (1994) 5.17
Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci (2004) 5.10
Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron (2004) 4.88
Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci U S A (2003) 4.80
Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD. Science (1999) 4.43
Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology (1996) 4.42
Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem (2005) 4.23
Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat Neurosci (2000) 4.10
CREB phosphorylation and dephosphorylation: a Ca(2+)- and stimulus duration-dependent switch for hippocampal gene expression. Cell (1996) 4.08
Risk of Alzheimer's disease and duration of NSAID use. Neurology (1997) 4.06
Immune function of astrocytes. Glia (2001) 4.05
Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell (2001) 3.55
Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron (2008) 3.46
Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci U S A (1979) 3.33
Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum. Proc Natl Acad Sci U S A (1993) 3.16
Microglia: intrinsic immuneffector cell of the brain. Brain Res Brain Res Rev (1995) 2.92
Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression. Nature (1996) 2.90
Purification of cyclic 3',5'-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose. Biochemistry (1978) 2.89
Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron (1996) 2.86
Neuronal activity triggers calcium waves in hippocampal astrocyte networks. Neuron (1992) 2.85
Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell (2001) 2.62
Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci U S A (1993) 2.62
Widespread activation of calcium-activated neutral proteinase (calpain) in the brain in Alzheimer disease: a potential molecular basis for neuronal degeneration. Proc Natl Acad Sci U S A (1993) 2.58
The role of microglia and macrophages in the pathophysiology of the CNS. Prog Neurobiol (1999) 2.46
Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci (2010) 2.46
Characterization of Ca2+/calmodulin-dependent protein kinase IV. Role in transcriptional regulation. J Biol Chem (1994) 1.94
Restricted and regulated overexpression reveals calcineurin as a key component in the transition from short-term to long-term memory. Cell (1998) 1.85
AMPA receptor trafficking and long-term potentiation. Philos Trans R Soc Lond B Biol Sci (2003) 1.85
Neurons, glia, and plasticity in normal brain aging. Neurobiol Aging (2003) 1.82
Inducible and reversible gene expression with the rtTA system for the study of memory. Neuron (1998) 1.81
Prolonged Ca2+-dependent afterhyperpolarizations in hippocampal neurons of aged rats. Science (1984) 1.80
Calcium homeostasis and modulation of synaptic plasticity in the aged brain. Aging Cell (2007) 1.78
Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem (2005) 1.64
Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J (1995) 1.60
Calcineurin triggers reactive/inflammatory processes in astrocytes and is upregulated in aging and Alzheimer's models. J Neurosci (2005) 1.55
Cognitive decline in Alzheimer's disease is associated with selective changes in calcineurin/NFAT signaling. J Neurosci (2009) 1.54
An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes. J Biol Chem (2000) 1.52
Intermediate- and long-term recognition memory deficits in Tg2576 mice are reversed with acute calcineurin inhibition. Behav Brain Res (2009) 1.51
Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem (2007) 1.50
Early and simultaneous emergence of multiple hippocampal biomarkers of aging is mediated by Ca2+-induced Ca2+ release. J Neurosci (2006) 1.48
Calcineurin links Ca2+ dysregulation with brain aging. J Neurosci (2001) 1.41
Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus. Neurobiol Learn Mem (2002) 1.37
Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol Aging (2008) 1.35
Calcineurin regulation of synaptic function: from ion channels to transmitter release and gene transcription. Trends Pharmacol Sci (1997) 1.32
Calcineurin regulation of neuronal plasticity. Biochem Biophys Res Commun (2003) 1.32
Interleukin-1beta-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem (2008) 1.29
High level calcineurin activity predisposes neuronal cells to apoptosis. J Biol Chem (1999) 1.28
Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type. Brain Res (1999) 1.24
Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence. CNS Neurol Disord Drug Targets (2010) 1.21
An allosteric model of calmodulin explains differential activation of PP2B and CaMKII. Proc Natl Acad Sci U S A (2008) 1.18
Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J Neurosci Res (2010) 1.17
Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Aging Cell (2008) 1.15
Calcineurin enhances L-type Ca(2+) channel activity in hippocampal neurons: increased effect with age in culture. Neuroscience (2002) 1.15
Amyloid beta prevents activation of calcium/calmodulin-dependent protein kinase II and AMPA receptor phosphorylation during hippocampal long-term potentiation. J Neurophysiol (2004) 1.12
The distribution of calcineurin in rat brain by light and electron microscopic immunohistochemistry and enzyme-immunoassay. Brain Res (1986) 1.07
Overactivation of calcineurin induced by amyloid-beta and prion proteins. Neurochem Int (2008) 1.04
Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides. Eur J Neurosci (2003) 1.02
Antisense DNA against calcineurin facilitates memory in contextual fear conditioning by lowering the threshold for hippocampal long-term potentiation induction. Neuroscience (2000) 1.00
Microglial phenotype is regulated by activity of the transcription factor, NFAT (nuclear factor of activated T cells). J Neurosci (2010) 1.00
Hippocampal 'zipper' slice studies reveal a necessary role for calcineurin in the increased activity of L-type Ca(2+) channels with aging. Neurobiol Aging (2010) 0.98
Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur J Neurosci (2006) 0.91
Aging-related increases in voltage-sensitive, inactivating calcium currents in rat hippocampus. Implications for mechanisms of brain aging and Alzheimer's disease. Ann N Y Acad Sci (1989) 0.89
Involvement of calcineurin in Ca2+ paradox-like injury of cultured rat astrocytes. J Neurochem (1998) 0.89
Mechanical lesion activates newly identified NFATc1 in primary astrocytes: implication of ATP and purinergic receptors. Eur J Neurosci (2008) 0.87
A role for the protein phosphatase 2B in altered hippocampal synaptic plasticity in the aged rat. J Physiol Paris (2006) 0.87
Reduced calcium uptake by rat brain mitochondria and synaptosomes in response to aging. Brain Res (1985) 0.81
Reactive oxygen species (ROS) play an important role in a rat model of neuropathic pain. Pain (2004) 2.26
Dysregulated phosphorylation of Ca(2+) /calmodulin-dependent protein kinase II-α in the hippocampus of subjects with mild cognitive impairment and Alzheimer's disease. J Neurochem (2011) 1.56
Acute inhibition of calcineurin restores associative learning and memory in Tg2576 APP transgenic mice. Neurobiol Learn Mem (2007) 1.50
Potential role of α-synuclein in neurodegeneration: studies in a rat animal model. J Neurochem (2012) 1.41
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. Proteomics (2009) 1.23
Amyloid-beta oligomers impair fear conditioned memory in a calcineurin-dependent fashion in mice. J Neurosci Res (2010) 1.17
Selective induction of calcineurin activity and signaling by oligomeric amyloid beta. Aging Cell (2008) 1.15
Bcl-2 localized at the nuclear compartment induces apoptosis after transient overexpression. J Biol Chem (2006) 1.12
Blueberry supplemented diet: effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci (2004) 0.99
A role for calcineurin in Alzheimer's disease. Curr Neuropharmacol (2011) 0.97
α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases. J Neurochem (2011) 0.96
Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2. J Biol Chem (2004) 0.94
Absence of amyloid β oligomers at the postsynapse and regulated synaptic Zn2+ in cognitively intact aged individuals with Alzheimer's disease neuropathology. Mol Neurodegener (2012) 0.89
Proton-sensing G protein-coupled receptor mobilizes calcium in human synovial cells. Am J Physiol Cell Physiol (2005) 0.89
Selective, quantitative measurement of releasable synaptic zinc in human autopsy hippocampal brain tissue from Alzheimer's disease patients. J Neurosci Methods (2011) 0.88
Calcineurin inhibition at the clinical phase of prion disease reduces neurodegeneration, improves behavioral alterations and increases animal survival. PLoS Pathog (2010) 0.88
A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes. Am J Physiol Regul Integr Comp Physiol (2009) 0.88
Peripheral adipose tissue insulin resistance alters lipid composition and function of hippocampal synapses. J Neurochem (2015) 0.86
Up-regulation of Bcl-2 in APP transgenic mice is associated with neuroprotection. Neurobiol Dis (2006) 0.83
Free radical-dependent nuclear localization of Bcl-2 in the central nervous system of aged rats is not associated with Bcl-2-mediated protection from apoptosis. J Neurochem (2003) 0.82
Proteomic study of amyloid beta (25-35) peptide exposure to neuronal cells: Impact on APE1/Ref-1's protein-protein interaction. J Neurosci Res (2012) 0.81
Brain serum amyloid P levels are reduced in individuals that lack dementia while having Alzheimer's disease neuropathology. Neurochem Res (2011) 0.80
Tumour necrosis factor-alpha- vs. growth factor deprivation-promoted cell death: distinct converging pathways. Aging Cell (2003) 0.80
Signaling pathways mediating a selective induction of nitric oxide synthase II by tumor necrosis factor alpha in nerve growth factor-responsive cells. J Neuroinflammation (2005) 0.78
Free radical-dependent changes in constitutive Nuclear factor kappa B in the aged hippocampus. Neuroreport (2002) 0.78
Rapid assay for quantitative measurement of apoptosis in cultured cells and brain tissue. J Neurosci Methods (2006) 0.77
Tumour necrosis factor-alpha- vs. growth factor deprivation-promoted cell death: different receptor requirements for mediating nerve growth factor-promoted rescue. Aging Cell (2003) 0.76
Non-Demented Individuals with Alzheimer's Disease Neuropathology: Resistance to Cognitive Decline May Reveal New Treatment Strategies. Curr Pharm Des (2016) 0.76
Bcl-2 phosphorylation is not required for its effects on NFkappaB activity. Neuroreport (2003) 0.75